Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

1354 projects found matching your search criteria :

  1. Immune and metabolomic signatures in chidhood Mycobacterium tuberculosis infections

    Call: OPUS 11 , Panel: NZ7

    Principal investigator: dr Magdalena Ewa Druszczyńska

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

  2. Studying the molecular dynamics, phase transitions, isomerizations, at different temperature and pressure conditions in ...

    Call: SONATA BIS 6 , Panel: NZ7

    Principal investigator: dr hab. Ewa Iwona Ozimina-Kamińska

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej w Sosnowcu

  3. The Warburg effect in breast cancer - role of cadmium as the activator of HIF-1 alpha

    Call: SONATA 12 , Panel: NZ7

    Principal investigator: dr hab. Ewa Katarzyna Jabłońska

    INSTYTUT MEDYCYNY PRACY IM.PROF.DR MED.JERZEGO NOFERA W ŁODZI

  4. Using Nordic Walking mechatronic poles for modeling and evaluating the rehabilitation of selected groups of patients

    Call: OPUS 12 , Panel: NZ7

    Principal investigator: prof. Marek Woźniewski

    AKADEMIA WYCHOWANIA FIZYCZNEGO WE WROCŁAWIU, Wydział Fizjoterapii

  5. The role of synovial fibroblasts' activity in joint pain in osteoarthritis

    Call: OPUS 12 , Panel: NZ7

    Principal investigator: dr hab. Katarzyna Maria Starowicz-Bubak

    Instytut Farmakologii PAN

  6. Synthesis, toxicological and functional studies on mutli-walled carbon nanotubes as a scaffold for tissue engineering te...

    Call: OPUS 12 , Panel: NZ7

    Principal investigator: prof. Michał Giersig

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Centrum Zaawansowanych Technologii

  7. Effect of high intensity interval training on mechanisms of neuroplasticity and psychomotor behaviours in Parkinson's di...

    Call: OPUS 13 , Panel: NZ7

    Principal investigator: prof. Jarosław Marusiak

    AKADEMIA WYCHOWANIA FIZYCZNEGO WE WROCŁAWIU, Wydział Fizjoterapii

  8. Study of release and absorption into human body of bioelements and biologically active organic compounds from fruiting b...

    Call: PRELUDIUM 13 , Panel: NZ7

    Principal investigator: Katarzyna Joanna Kała

    Uniwersytet Jagielloński- Collegium Medicum, Uniwersytet Jagielloński - Collegium Medicum; Wydział Farmaceutyczny

  9. Interdisciplinary approach to the role of the GABA-ergic and glutamatergic neurotransmission in the effects of mephedron...

    Call: OPUS 13 , Panel: NZ7

    Principal investigator: dr hab. Barbara Izabela Budzyńska

    Uniwersytet Medyczny w Lublinie, Wydział Biomedyczny

  10. Evaluation of nervous system cells homeostasis in the experimental in vitro model of cobalamin deficiency as an approach...

    Call: PRELUDIUM 13 , Panel: NZ7

    Principal investigator: Zuzanna Gertruda Rzepka

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Farmaceutycznych w Sosnowcu

  11. Pharmacological and optogenetic investigation of the mechanism of action of Deep Brain Stimulation of the ventromedial p...

    Call: OPUS 13 , Panel: NZ7

    Principal investigator: prof. Mariusz Papp

    Instytut Farmakologii PAN

  12. The role of endoplasmic reticulum stress in the pathomechanisms of early-life stress-induced dysfunction of the prefrona...

    Call: OPUS 13 , Panel: NZ7

    Principal investigator: dr hab. Agnieszka Chocyk

    Instytut Farmakologii PAN

  13. A new approach to imaging and rapid microbiome identification in evaluation radiotherapy effects

    Call: OPUS 20 , Panel: NZ7

    Principal investigator: dr hab. Dorota Katarzyna Gabryś

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

  14. Influence of the route of administration of new psychoactive substances on their metabolic profile

    Call: SONATA 16 , Panel: NZ7

    Principal investigator: dr Magdalena Anna Popławska

    Narodowy Instytut Leków

  15. A new class of antimicrobial compounds. Design, synthesis and study of the mechanism of action.

    Call: PRELUDIUM BIS 2 , Panel: NZ7

    Principal investigator: dr hab. Sylwia Anna Rodziewicz-Motowidło

    Uniwersytet Gdański, Wydział Chemii

  16. Aging-associated, specific pathomechanisms of endothelial dysfunction in sepsis: pathway analysis and experimental thera...

    Call: WEAVE-UNISONO , Panel: NZ7

    Principal investigator: prof. Stefan Karol Chłopicki

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

  17. An innovative method of treating acute liver failure using amniotic stem cells isolated from the human placenta.

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: dr Patrycja Lukrecja Wieczorek

    Śląski Uniwersytet Medyczny w Katowicach, Centrum Medycyny Doświadczalnej

  18. Correlations between supramolecular structure, molecular dynamics, physico-chemical stability, and solubility in neat Ac...

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: dr Karolina Jurkiewicz

    UNIWERSYTET ŚLĄSKI, Wydział Nauk Ścisłych i Technicznych

  19. Short- and long-term health effects of air pollution in Eastern Poland

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: dr hab. Łukasz Kuźma

    Uniwersytet Medyczny w Białymstoku

  20. Multifunctional plant systems as a complex way of providing neuroprotective activity

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: dr Anna Stasiłowicz-Krzemień

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

  21. Searching for the power of hormesis - Effects of silver nanoparticles, graphene oxide (GO), and GO-Ag composite on the f...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Reyhaneh Seyed Alian

    UNIWERSYTET ŚLĄSKI, Wydział Nauk Przyrodniczych

  22. New 3-methoxypropanamide derivatives in search of effective substances for the treatment of neurological diseases - epil...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Marcin Konrad Jakubiec

    Uniwersytet Jagielloński, Collegium Medicum

  23. Genetic and epigenetic interaction of exposure to endocrine disrupting chemicals included in everyday use products and e...

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: prof. Joanna Katarzyna Jurewicz

    INSTYTUT MEDYCYNY PRACY IM.PROF.DR MED.JERZEGO NOFERA W ŁODZI

  24. Novel combination therapies of pulmonary arterial hypertension targeting blockade of peripheral cannabinoid CB1 receptor...

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: prof. Barbara Malinowska

    Uniwersytet Medyczny w Białymstoku

  25. Neurobiological mechanisms of migraine pain - role of opioid and NOP systems

    Call: SONATA BIS 11 , Panel: NZ7

    Principal investigator: dr hab. Katarzyna Małgorzata Targowska-Duda

    Uniwersytet Medyczny w Lublinie

  26. Extracellular vesicles produced by Bifidobacterium as novel approach fortreatment of allergy diseases

    Call: OPUS 22 (LAP) , Panel: NZ7

    Principal investigator: dr hab. Sabina Barbara Górska

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  27. New post-treatment strategy against stroke and perinatal asphyxia – a novel approach based on a selective activation of ...

    Call: SONATA 17 , Panel: NZ7

    Principal investigator: dr hab. Agnieszka Wnuk

    Instytut Farmakologii PAN

  28. Searching for the mechanisms inducing improvement in motor function and prolonging the lifespan in amyotrophic lateral s...

    Call: SONATA 17 , Panel: NZ7

    Principal investigator: dr Damian Józef Flis

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

  29. Non-provitamin A carotenoids as a novel therapeutic strategy in intestinal failure associated liver disease (IFALD)

    Call: PRELUDIUM BIS 3 , Panel: NZ7

    Principal investigator: dr hab. Maciej Jan Stawny

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  30. Exosomes as a potential biomarker for monitoring and predicting kidney allograft rejection.

    Call: OPUS 22 , Panel: NZ7

    Principal investigator: dr hab. Justyna Eliza Gołębiewska

    Gdański Uniwersytet Medyczny, Wydział Lekarski

  31. Light-producing, oxygen-delivering, cancer cell-targeted carriers for photosensitisers dedicated for photodynamic therap...

    Call: OPUS 22 , Panel: NZ7

    Principal investigator: prof. Marek Arkadiusz Murias

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  32. MOF-antidote": Novel detoxification materials based on metal organic-frameworks for drugs of abuse removal - synthesis, ...

    Call: OPUS 22 , Panel: NZ7

    Principal investigator: dr hab. Przemysław Jakub Jodłowski

    Politechnika Krakowska im. Tadeusza Kościuszki

  33. Electrospun nanofiber-based nanoplatform for delivery of new nutraceutical derivatives to eliminate chemotherapy-induced...

    Call: OPUS 22 , Panel: NZ7

    Principal investigator: dr hab. Maciej Antoni Wnuk

    Uniwersytet Rzeszowski, Collegium Medicum

  34. The use of genetic analysis of liquid biopsy for predicting and monitoring ofresponse to therapies and tumor evolution i...

    Call: OPUS 22 , Panel: NZ7

    Principal investigator: dr Magdalena Olbryt

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

  35. Enhancement of antidepressant therapy by combined administration of hyperforin and ketamine: behavioral and molecular st...

    Call: SONATA 17 , Panel: NZ7

    Principal investigator: dr Bartłomiej Pochwat

    Instytut Farmakologii PAN

  36. The application of artificial intelligence to the discovery of new natural drugs with mechanisms aimed at lowering free ...

    Call: PRELUDIUM 21 , Panel: NZ7

    Principal investigator: Maciej Spiegel

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej, Wydział Farmaceutyczny

  37. Combination of FAAH inhibition with action via serotonin 5-HT6 receptor as pioneering approach to fight with Alzheimer D...

    Call: PRELUDIUM 21 , Panel: NZ7

    Principal investigator: Kinga Maria Czarnota-Łydka

    Uniwersytet Jagielloński, Collegium Medicum

  38. Understanding drug/polymer/plasticizer miscibility and its effect on mechanical properties of polymeric filaments for FD...

    Call: PRELUDIUM 21 , Panel: NZ7

    Principal investigator: Marta Maria Kozakiewicz-Latała

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

  39. Studies on the post-receptor mechanisms of TSPO in search of a novel therapeutic target of metabolic syndrome

    Call: PRELUDIUM 21 , Panel: NZ7

    Principal investigator: dr Łukasz Kurach

    Uniwersytet Medyczny w Lublinie

  40. High-throughput PET imaging by decoding multi-photon signals on long axial field-of-view PET using physics-guided artifi...

    Call: OPUS 24 (LAP) , Panel: NZ7

    Principal investigator: prof. Ewa Łucja Stępień

    Uniwersytet Jagielloński, Wydział Fizyki, Astronomii i Informatyki Stosowanej

  41. Evaluation of anti-neoplastic activity of LAB-derived postbiotics as a potential tool to support standard chemotherapy i...

    Call: PRELUDIUM BIS 4 , Panel: NZ7

    Principal investigator: prof. Janusz Zbigniew Szemraj

    Uniwersytet Medyczny w Łodzi, Wydział Nauk o Zdrowiu

  42. Development of novel anti-cancer immunotherapy against mesothelioma comprising of oncolytic adenovirus vectors armed wit...

    Call: SONATA 18 , Panel: NZ7

    Principal investigator: dr Łukasz Kuryk

    Narodowy Instytut Zdrowia Publicznego - Państwowy Zakład Higieny (NIZP - PZH)

  43. Potential of TH cell profiling in personalized multiple sclerosis treatmentplanning.

    Call: OPUS 24 , Panel: NZ7

    Principal investigator: dr hab. Katarzyna Donskow-Łysoniewska

    Uczelnia Łazarskiego

  44. CHIRAL RHENIUM AND RHODIUM COMPLEXES OF ANTICANCER AND ANTIBACTERIAL ACTIVITY: SYNTHESIS, ACTIVITY, AND PHYSICOCHEMICAL ...

    Call: OPUS 24 , Panel: NZ7

    Principal investigator: prof. Jan Czesław Dobrowolski

    Narodowy Instytut Leków

  45. Unveiling the molecular signature underlying resistance to CD19 CAR-T therapy in malignant cells.

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Marta Krawczyk

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  46. Toxicity prediction for Novichoks: estimation of selected toxicological parameters for Novichoks as organophosphorus com...

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: dr Maciej Noga

    Instytut Ekspertyz Medycznych w Łodzi

  47. unESKAPEable. Innovative antibiotics leads based on bifunctionalsed metallacarboranes to combat ESKAPE pathogens.

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Jakub Cebula

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  48. The Role of the Mitochondrial Unfolded Protein Response (UPRmt) in Endothelial Function: a Possible Novel Target for the...

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Sylwester Tycjan Mosiołek

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

  49. Assessment of twin screw extrusion potential as a continuous and scalable method of mechanochemical synthesis of active ...

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Anna Magdalena Gołkowska

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej, Wydział Farmaceutyczny

  50. Are bisphenol S and F safe substitutes for bisphenol A in the face of environmental contamination with estrogenic mycoto...

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Marta Justyna Kozieł

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski